Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-004338

Chief Executive Officer sold 600 shares at $30.38 ($18,228)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ciechanover Isaac E. Chief Executive Officer 2018-01-16 Sale −600 $30.38 $18,228 359,478 I
Open-market sales · 600 sh · avg $30.38 · $18,228
Loading xslF345X03/doc4.xml…